Chapter 10. Newer Markers for Population Screening: Focus on Lipoprotein-Related Markers

  1. James A. de Lemos MD Associate Professor of Medicine Coronary Care Unit Director
  1. Vijay Nambi MD Assistant Professor of Medicine1,
  2. Ron C. Hoogeveen PhD Assistant Professor of Medicine2 and
  3. Christie Ballantyne MD Professor of Medicine1

Published Online: 13 JAN 2009

DOI: 10.1002/9781444300208.ch10

Biomarkers in Heart Disease

Biomarkers in Heart Disease

How to Cite

Nambi, V., Hoogeveen, R. C. and Ballantyne, C. (2008) Newer Markers for Population Screening: Focus on Lipoprotein-Related Markers, in Biomarkers in Heart Disease (ed J. A. de Lemos), Blackwell Publishing Ltd., Oxford, UK. doi: 10.1002/9781444300208.ch10

Editor Information

  1. University of Texas Southwestern Medical Center Dallas, TX, USA

Author Information

  1. 1

    Section of Atherosclerosis and Vascular Medicine, Baylor College of Medicine, Center for Cardiovascular Prevention, Methodist DeBakey Heart Center, Houston, TX, USA

  2. 2

    Section of Atherosclerosis and Vascular Medicine, Baylor College of Medicine, The Methodist Hosptial, Houston, TX, USA

Publication History

  1. Published Online: 13 JAN 2009
  2. Published Print: 18 APR 2008

Book Series:

  1. The AHA Clinical Series

Book Series Editors:

  1. Elliott Antman

ISBN Information

Print ISBN: 9781405175715

Online ISBN: 9781444300208

SEARCH

Keywords:

  • lipoprotein-related biomarkers;
  • C-reactive protein (CRP) and lipoprotein-associated phospholipase A2 (Lp-PLA2);
  • apolipoprotein B level;
  • ATP III guidelines and LDL-C levels;
  • low-density lipoprotein particle size and number;
  • high-density lipoprotein subclasses;
  • lipoprotein-associated phospholipase A2 (Lp-PLA2)

Summary

This chapter contains sections titled:

  • Introduction

  • Lipoprotein-related biomarkers

  • Conclusion and recommendations

  • References